PROCEPT BioRobotics Corporation
PRCT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $224,498 | $136,191 | $75,014 | $34,473 |
| % Growth | 64.8% | 81.6% | 117.6% | – |
| Cost of Goods Sold | $87,399 | $65,142 | $37,929 | $18,608 |
| Gross Profit | $137,099 | $71,049 | $37,085 | $15,865 |
| % Margin | 61.1% | 52.2% | 49.4% | 46% |
| R&D Expenses | $62,298 | $48,446 | $28,981 | $18,993 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $171,415 | $131,773 | $88,828 | $51,036 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $233,713 | $180,219 | $117,809 | $70,029 |
| Operating Income | -$96,614 | -$109,170 | -$80,724 | -$54,164 |
| % Margin | -43% | -80.2% | -107.6% | -157.1% |
| Other Income/Exp. Net | $5,201 | $3,273 | -$6,430 | -$5,689 |
| Pre-Tax Income | -$91,413 | -$105,897 | -$87,154 | -$59,853 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$91,413 | -$105,897 | -$87,154 | -$59,853 |
| % Margin | -40.7% | -77.8% | -116.2% | -173.6% |
| EPS | -1.75 | -2.24 | -1.96 | -3.63 |
| % Growth | 21.9% | -14.3% | 46% | – |
| EPS Diluted | -1.75 | -2.24 | -1.96 | -3.63 |
| Weighted Avg Shares Out | 52,125 | 47,255 | 44,400 | 16,480 |
| Weighted Avg Shares Out Dil | 52,125 | 47,255 | 44,400 | 16,480 |
| Supplemental Information | – | – | – | – |
| Interest Income | $10,895 | $7,551 | $2,497 | $76 |
| Interest Expense | $4,184 | $3,995 | $5,183 | $5,810 |
| Depreciation & Amortization | $5,234 | $3,807 | $2,841 | $3,324 |
| EBITDA | -$81,995 | -$98,095 | -$79,130 | -$50,719 |
| % Margin | -36.5% | -72% | -105.5% | -147.1% |